Legal Representation
Attorney
J. Gregory Chrisman
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 2, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 2, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 1, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 27, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 27, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 27, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 18, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 16, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 16, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 16, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 16, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 14, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 14, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 14, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 31, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 6, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 6, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 16, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 2, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 29, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 12, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
syringes, vials, bags, auto-injectors, sublingual drug delivery devices, and intranasal drug delivery devices, all prefilled with pharmaceutical preparations and substances, namely, systemic anti-infectives, pharmaceutical and medicinal substances for the prevention, curing, and treatment of viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders; pharmaceutical and medicinal substances for the prevention, curing, and treatment of allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders
Classification
International Classes
005